An observational real world study of benvitimod cream in the treatment of psoriasis

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041261

Enrollment

Unknown

Registered

2020-12-23

Start date

2020-12-21

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

case series:benvitimod cream

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Aged >= 18 years, regardless of gender; (2) A definite diagnosis of psoriasis requires symptomatic treatment with Benweimod cream. (3) There is no limit to the amount of Benweimod cream purchased through regular channels on or after June 1, 2020.

Exclusion criteria

Exclusion criteria: (1) Those who are known to be allergic to the active ingredients or excipients of the drugs under study; (2) Participated in other interventional clinical studies, including any drug or device clinical studies, within 30 days before enrollment; (3) Patients who are unwilling or unable to follow treatment or follow-up.

Design outcomes

Primary

Measure	Time frame
Psoriasis area and severity index;	—

Countries

China

Contacts

Public ContactDan Jia

jiadan@yuanxin-inc.com+86 13811794135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026